';
Featured
Featured posts

RCPA was honored to have Stacy DiStephano of Consulting for Human Services, LLC and Ross Harper of Limbic AI join us for a discussion regarding the use of clinical AI in behavioral health care. The recording is now available on RCPA’s website; you will need to log in to your RCPA member account to access. If you have any questions regarding the content or recording, please contact Carol Ferenz. You can find more information below on the speakers and their respective organizations.

Speaker Bios:

Stacy DiStefano, Founder and CEO of Consulting for Human Services, LLC, is a passionate and dynamic healthcare and human services executive advisor, strategist, and retained leader. She has worked on high level strategic initiatives for behavioral health provider organizations, private equity firms, state departments, and tech vendors. Stacy is a visionary with a clinical background, enabling growth and mission achievement. She also works as a trusted advisor who easily builds rapport and works in collaboration with key stakeholders. A resilient and creative problem-solver with an eye on efficiency and a track record of improving financial performance, Stacy always strives to solve complex challenges.

Ross Harper, PhD, CEO of Limbic AI, is a distinguished computational neuroscientist with a rich academic background. Holding a PhD in Computational Neuroscience and a Master’s in Mathematical Modeling from University College London as well as a Master’s in Natural Sciences from the University of Cambridge, Ross possesses an intricate understanding of the overlap between mathematics, technology, and the human mind. He launched Limbic AI in 2020 to enable large language models and generative AI to aid and assist processes in the mental health space, supporting clinicians and their patients within the NHS during the pandemic. Used by over 230,000 patients and mental health professionals within the NHS, Ross is leading a company that is improving patient access to mental health resources, speeding up diagnosis, and supporting mental health professionals to avoid burnout as the company prepares to expand into the US.

Limbic AI:

Limbic is a clinically-validated AI copilot to drive quality and efficiency in behavioral healthcare, drastically improving service operating margins while demonstrably improving patient outcomes. Limbic has been proven at scale in the UK, currently working with 40% of the National Health Service, which now implements Limbic as part of routine care (used by 320,000 patients already). In 2024, Limbic has published 3 large-scale clinical studies, showing improved patient outcomes, lower cost-per-recovery, expanded provider capacity, enhanced access for underserved communities, reduced patient wait times, and elevated satisfaction for patients and clinicians (Nature MedicineJMIRBritish Medical Journal). The company is now working with community health providers in the United States to deliver economic and clinical ROI.

Photo by Markus Winkler on Unsplash

Deputy Secretary Ahrens of the Office of Developmental Programs (ODP) shared a PowerPoint today, July 25, 2024, at the MAAC meeting. Highlights included ODP’s plan to publish several documents. ODP will be submitting waiver amendments for the 1915(c) waiver and the new 1915 (b)(4) waiver to the Centers for Medicare & Medicaid Services (CMS) on July 26, 2024. In addition, ODP Bulletin 00-24-01: Performance-Based Standards for Residential Services and an ODP announcement regarding the waiver submission, including an implementation guide and provider self-assessment, will be released tomorrow, July 26.

RCPA will share these documents with members as soon as they are available.

    0 769

    Congratulations to Melissa McGuire, who is retiring on July 26 after 29 years as RCPA member Evergreen Elm’s Residential Executive Director!

    The Pennsylvania Department of Drug and Alcohol Programs (DDAP) has issued Licensing Alert 06-2024 to notify licensed treatment facilities and recovery houses of the new process for submitting licensing regulations exceptions and facility requests to DDAP. This licensing alert replaces Licensing Alert 23-03 and is a result of DDAP streamlining its internal processes. The licensing alert explains how to submit exception requests and facility requests electronically.

    Questions about the alert or the new process should be directed to DDAP.

    The Department of Human Services (DHS) Office of Mental Health and Substance Abuse Services (OMHSAS) and Office of Developmental Programs (ODP) have announced that they are holding their Statewide Quarterly Positive Approaches & Practices virtual meeting on Thursday, August 8. The meeting will be held from 10:30 am – 3:00 pm, and the topic will be “Building Dementia Friendly Pennsylvania.”

    View the flyer for detailed session and registration information.

    The agenda for the August 7, 2024, Long-Term Services and Supports (LTSS) Subcommittee meeting has been released. The meeting is hybrid and will be held for in-person attendees in the Honors Suite, 1st floor, 333 Market Street, Harrisburg, PA 17126. The meeting is scheduled for 10:00 am – 1:00 pm. Comments and questions may be sent electronically. Details for attending via webinar can be found below:

    The Office of Developmental Programs (ODP) has shared an important announcement from the US Food and Drug Administration (FDA) about a recall of Clonazepam Orally Disintegrating Tablets due to mislabeling of the carton. This medication may be used in the treatment of Lennoz-Gastaut syndrome (petit mal variant), akinetic, myoclonic seizures, and panic disorders. Endo USA, Inc. is recalling USP (C-IV) Lot Number 550147301 due to the incorrect strength being on the product. If you have this product with the matching Lot Number, stop use immediately and contact your health care provider.

    Today, ID/A associations met with Secretary Arkoosh and Dep. Secretary Kristin Ahrens to better understand the FY 2024–25 budget. The Secretary expressed gratitude for our collective advocacy over the past year. She relayed that this budget was a hard-fought battle. Although DHS did not receive the proposed amount, $354 million in new funding is a significant investment. The administration is committed to eliminating the emergency waiting list and made it clear Performance-Based Contracting is moving forward. The administration is committed to building a stronger system and wants to continue to work on these priorities together.

    Here are a few technical updates regarding the FY 2024–25 budget:

    1. New rates are anticipated to be published on August 31st, to be effective October 1st, and retroactive to July 1st
      1. Non-residential rates expected to go up by 8% across the board
      2. Residential rates expected to go up by 6% across the board
      3. Providers are encouraged to bill at the current rates and expect a gross adjustment sometime after October 1st
    2. Changes to PBC are anticipated to be published on July 26th as follows:
      1. The rate add-on for clinically enhanced providers is expected to be 5%
      2. The rate add-on for select providers is expected to be 3%
      3. Pay for performance is expected to receive more funding, in order to open more categories for select and clinically enhanced providers

    For any questions, contact Richard Edley or Carol Ferenz.